ETF Managers Group’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $70.8K | Buy |
7,197
+2,014
| +39% | +$19.8K | ﹤0.01% | 654 |
|
|
2022
Q4 | $97K | Sell |
5,183
-950
| -15% | -$17.8K | ﹤0.01% | 492 |
|
|
2022
Q3 | $127K | Buy |
6,133
+103
| +2% | +$2.13K | ﹤0.01% | 639 |
|
|
2022
Q2 | $130K | Buy |
6,030
+712
| +13% | +$15.4K | ﹤0.01% | 672 |
|
|
2022
Q1 | $233K | Buy |
5,318
+19
| +0.4% | +$832 | ﹤0.01% | 593 |
|
|
2021
Q4 | $330K | Sell |
5,299
-1,102
| -17% | -$68.6K | 0.01% | 588 |
|
|
2021
Q3 | $558K | Buy |
6,401
+1,254
| +24% | +$109K | 0.01% | 507 |
|
|
2021
Q2 | $584K | Sell |
5,147
-159
| -3% | -$18K | 0.01% | 477 |
|
|
2021
Q1 | $561K | Sell |
5,306
-1,561
| -23% | -$165K | 0.01% | 398 |
|
|
2020
Q4 | $742K | Sell |
6,867
-2,054
| -23% | -$222K | 0.02% | 272 |
|
|
2020
Q3 | $1.21M | Buy |
8,921
+3,753
| +73% | +$509K | 0.04% | 188 |
|
|
2020
Q2 | $1.97M | Buy |
+5,168
| New | +$1.97M | 0.07% | 144 |
|